Contact this trialFirst, we need to learn more about you.
Glucagon-like peptide-1 receptor agonist
Liraglutide for Type 2 Diabetes
Recruiting3 awardsPhase 4
Philadelphia, Pennsylvania
This trial tests if Liraglutide can reduce stress in fat tissue and improve health in obese patients with type 2 diabetes. The medication helps control blood sugar and appetite, potentially offering better management for these patients. Liraglutide is used for weight management and glycemic control in patients with type 2 diabetes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service